Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
YHLO has over a decade of experience with a commercial portfolio exceeding over 300 diagnostic products, widely adopted across hospitals and clinics in China (>70% coverage rate at top-tier hospitals), with international reach into nearly 115 countries/regions. Their tests have been cited in more than 980 scientific publications, reflecting broad clinical adoption and validation
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on YHLO Biotech.